Noncoding Cancer Biomarkers and Therapeutics Group
@NoncodingG
We are a team of researchers whose shared goal is to further our understanding of the role non-coding genomic factors play in the development of cancer.
Presentations from our group members at the 2023 Australian Association of Chinese Biomedical Scientists Annual Meeting. Huge congrats to our PhD student, Ran Xu, for his best oral presentation award. Well deserved๐@xudongzhang15@LeiJin83480165
Congrats to @RanXu_UON on an amazing 3min thesis. Cutting the power to cancer cells to cure cancer! Supported by the @XuDongZhang15@NoncodingG team. Flying the flag in the finals for our amazing School of Biomedical Sciences + Pharmacy @UON_research @HMRIAustralia
Huge congratulations to our PhD student Ran Xu to be one of the winners for the College 3MT. Very well done! Looking forward to your presentation at the University Final. Big congratulations to all the winners too.
Check out today's Cure Cancer Lunch & Learn session with our post-doc Dr Yuchen Feng and Cure Cancer CEO Nikki Kinloch about her research - lncRNA potentials as biomarkers and therapeutic targets - funded by Cure Cancer. @CureCancerAu @UON_research
https://t.co/5maGIHnyUq
Congratulations to our PhD student Liang Xu for successfully passing his PhD confirmation! Well done๐๐
Many thanks to our consumer representatives for attending Liang's confirmation and providing feedbacks on our research program. Much appreciate your support!
Huge congratulations to Dr Yuchen Feng from our group for her success in the 2023 Cure Cancer Early Career Grant. Well done๐๐!
@UON_research @Uni_Newcastle@PrecisionMedUON@HMRIAustralia
https://t.co/cEPxLQyvcM
Happy new year with a new publication from our group! Check out our new paper online today in Advanced Science about a lncRNA LIMp27 that regulates DNA damage response in p53-defective cancer cells.
https://t.co/VzkgtSYdW4
Researcher @XuDongZhang15 and his team from the #HMRI_CancerDetectionAndTherapy Research Program have discovered a way to combat a form of cancer most common in children under five โ #neuroblastoma.
Read more ๐ https://t.co/ns2bwBqmCD
New publication! Excited to share our work published in PNAS. Targeting lncRNA MILIP using GapmeR sensitises neuroblastoma cells to DNA-damaging therapies.
https://t.co/vI9X4ziYgA
Congratulations to our PhD students, Ran Xu and Xiaohong Zhao, for their excellent performance - being awarded the first and second best oral presentation awards - in the AACBS annual meeting in Sydney. Well done!
Huge congratulations to our PhD students, Xiaohong Zhao and Haijie Tang, being awarded the People's Choice Student Presentation and the People's Choice Student Poster at the 2022 Cancer and Precision Medicine Symposium. Well deserved!
Our group #XuDongZhang#LeiJin has been focused on exploring lncRNA roles in cancer. Check out our new publication in Journal of Experimental and Clinical Cancer Research https://t.co/u3F1yWcrZK, exploring a new role of lncRNA MILIP in clear cell renal cell carcinoma metastasis.
Huge congrats to Prof Xu Dong Zhang on his successful #NHMRC Investigator Grant ($2.3M) to explore long noncoding RNAs for cancer diagnosis and treatment๐๐๐@XuDongZhang15@precisionMedUON@HMRIAustralia
It has been a tough year due to COVID, but it's great to look back and see what we have achieved despite the hardships. Congratulations to @xiaohongzhao4 and @YuchenFeng2020 for their recognition at at the CHMW Staff Celebration
Huge congratulations to @YuchenFeng2020 for her success in securing a Cancer Institute NSW Early Career Fellowship. Her achievement came on the back of a lot of hard work and commitment. We predict that her research will have a significant impact in the field of cancer biology.
Congratulations to Dr Yuchen Feng and the team for their publication on the pan-cancer lncRNA "PLANE". If you want to find out more, check out our blog at cancer community @nature
https://t.co/hlNnz2k1qe